Anti-CD19 CAR-T Cells (Shaanxi Provincial People'S Hospital)

N/A

Report date: 2023/06/07 11:32:54

Base Information

Drug NameAnti-CD19 CAR-T Cells (Shaanxi Provincial People'S Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionAnti-CD19
TargetsB-lymphocyte antigen CD19
Therapy Area/IndicationsLeukemia, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesShaanxi Provincial People'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShaanxi Provincial People'S Hospital
Inactive CompaniesN/A
Active IndicationsLeukemia, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A